SCHEMBL3949236

SCHEMBL3949236

COC(=O)CCc1ccc(OC)c(N)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.57
ALDH1A1 P00352 2/20 0.50
ALOX5 P09917 1/20 0.50
OR51E2 Q9H255 1/20 0.50
LMNA P02545 1/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
GFER P55789 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP19A1 P11511 2/20 0.46
PTPN1 P18031 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
REN P00797 1/20 0.44
CTSD P07339 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7283109 0.88 ALDH1A1 (0.57) GAAALDH1A1ALOX5OR51E2GFER
SCHEMBL7398838 0.86 GAA (0.59) GAAALDH1A1ALOX5OR51E2LMNA
Hydrochloric Acid SCHEMBL6986396 0.85 CYP4F2 (0.54) GAAALDH1A1ALOX5OR51E2LMNA
SCHEMBL3940302 0.85 KMT2A (0.59) ALDH1A1ALOX5OR51E2MEN1KMT2A
SCHEMBL18046156 0.85 ALDH1A1 (0.53) GAAALDH1A1ALOX5OR51E2LMNA
SCHEMBL7247237 0.84 ALDH1A1 (0.69) GAAALDH1A1LMNAHTTL3MBTL1
Hydrochloric Acid SCHEMBL6983661 0.83 ALDH1A1 (0.67) GAAALDH1A1LMNAHTTL3MBTL1
SCHEMBL11216725 0.83 ALDH1A1 (0.71) GAAALDH1A1ALOX5OR51E2GFER
SCHEMBL28287006 0.83 CYP19A1 (0.65) GAAALOX5OR51E2LMNAMEN1
SCHEMBL22187923 0.81 ALDH1A1 (0.49) GAAALDH1A1ALOX5OR51E2GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1285908-B9 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES KYORIN SEIYAKU KK (JP) 2009-04-22 EP disclosed
EP-1285908-B1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES KYORIN SEIYAKU KK (JP) 2008-09-10 EP disclosed
US-7049342-B2 Substituted phenylpropionic acid derivatives KYORIN PHARMACEUTICAL CO., LTD. (JP) 2006-05-23 US disclosed
US-20030187068-A1 Substituted phenylpropionic acid derivatives KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-10-02 US disclosed
EP-1285908-A1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187068-A1 Substituted phenylpropionic acid derivatives PPARA, PPARG, PPARD GAA 2420/4885ALDH1A1 429/4885ALOX5 1110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.